Russian schoolchildren's chronic illnesses triple by graduation, study reveals
Russian schoolchildren's chronic illnesses triple by graduation, study reveals
Russian schoolchildren's chronic illnesses triple by graduation, study reveals
Russian schoolchildren are facing a growing burden of chronic health issues, according to recent findings. Deputy Health Minister Natalia Belotskaya highlighted troubling trends, including a sharp rise in illnesses as students progress through their education. The data points to widespread problems across multiple body systems, from vision to digestion and beyond. One of the most striking figures reveals that chronic illnesses among schoolchildren triple by the time they finish school compared to their first year. Vision problems remain the most frequently reported issue, affecting a large portion of students. Alongside this, nervous system disorders are also widespread, raising concerns about long-term mental and physical well-being.
Digestive diseases appear frequently in health reports, alongside endocrine and musculoskeletal problems. Reproductive system disorders, though less common, still affect 2.2% of students. Belotskaya's remarks suggest that current healthcare efforts may need to shift focus toward younger age groups, particularly preschoolers and those in vocational schools and colleges. The available data does not cover recent trends in visual impairments or obesity among Russian schoolchildren over the past five years. Instead, it draws attention to broader disease statistics and mental health patterns observed in both Russia and Germany.
The findings underscore a clear pattern: schoolchildren develop significantly more health problems as they advance through their studies. With chronic conditions rising sharply, authorities may need to reassess prevention and early intervention strategies. The emphasis now lies on addressing these issues before they become more severe in later years.
MannKind's inhalable insulin Afrezza eyes paediatric approval by 2026
A game-changing inhalable insulin could soon reach children with diabetes. Can MannKind's bold moves finally turn the tide for Afrezza?
Neocor secures $3.8M to revolutionize heart valve production by 2027
From Soviet-era labs to cutting-edge implants: Neocor's breakthrough could make life-saving heart valves accessible to millions. But first, they must win over surgeons—and regulators.
Breakthrough Therapy for Stubborn Vascular Blockages Unveiled at Medical Event
A revolutionary approach to clearing stubborn arterial deposits could transform PAOD care. Free screenings and lab tours bring cutting-edge vascular medicine to the public.
Russian schoolchildren's chronic illnesses triple by graduation, study reveals
From first grade to graduation, their health declines sharply. Experts warn of a crisis in vision, digestion, and mental well-being among young learners.